Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study

1. Martín, M.
2. Zielinski, C.
3. Ruiz-Borrego, M.
4. Carrasco, E.
5. Ciruelos, E.M.
6. Muñoz, M.
7. Bermejo, B.
8. Margelí, M.
9. Csöszi, T.
10. Antón, A.
11. Turner, N.
12. Casas, M.I.
13. Morales, S.
14. Alba, E.
15. Calvo, L.
16. de la Haba-Rodríguez, J.
17. Ramos, M.
18. Murillo, L.
19. Santaballa, A.
20. Alonso-Romero, J.L.
21. Sánchez-Rovira, P.
22. Corsaro, M.
23. Huang, X.
24. Thallinger, C.
25. Kahan, Z.
26. Gil-Gil, M.
27. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.EJCA.2022.03.006 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus